EP3102199
THERAPY REGIMEN AND METHODS TO SENSITIZE CANCER CELLS TREATED WITH EPIGENETIC THERAPY TO PARP INHIBITORS IN MULTIPLE CANCERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.1.2015EP published:
22.7.2020EP application number:
15740207.4
EPO information:
European Patent Register
Max expiry date:
20.1.2035
Title:
THERAPY REGIMEN AND METHODS TO SENSITIZE CANCER CELLS TREATED WITH EPIGENETIC THERAPY TO PARP INHIBITORS IN MULTIPLE CANCERS
Timeline
Today
21.1.2015EP application
22.7.2020EP Publication
Owner
Name:
The Johns Hopkins UniversityAddress:
3400 North Charles Street, Baltimore, MD 21218, US
Name:
University of Maryland, BaltimoreAddress:
Office of Technology Transfer 620 W.Lexington Street, 4th Floor, Baltimore MD 21201, US
Inventor
Name:
RASSOOL, FeyruzAddress:
Baltimore, Maryland 21203, US
Name:
BAYLIN, StephenAddress:
Baltimore, Maryland 21230, US
Name:
ROBERT, CarineAddress:
F-75018 Paris, FR
Priority
Number:
201461929680 PDate:
21.1.2014Country:
US
Classification
Categories:
A61K 31/513, A61K 31/53, A61K 31/5025, A61K 31/4184, A61P 35/00